FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nils Koch-Henriksen

Research Profile

Disorders

Geographic Areas

Denmark

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Bjørn A Nexø; Lars Pedersen; Henrik Toft Sørensen; Nils Koch-Henriksen
Treatment of HIV and risk of multiple sclerosis.
Poul Thirup; Nils Koch-Henriksen; Per Soelberg Sørensen
[Multiple Sclerosis Treatment Registry].
Poul Erik H Jensen; Nils Koch-Henriksen; Finn Sellebjerg; Per S Sørensen
Prediction of antibody persistency from antibody titres to natalizumab.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nils Koch-Henriksen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bjørn A Nexø; Lars Pedersen; Henrik Toft Sørensen; Nils Koch-Henriksen
Treatment of HIV and risk of multiple sclerosis.
Epidemiology (Cambridge, Mass.) 2013;24(2):331-2.
2012: Poul Thirup; Nils Koch-Henriksen; Per Soelberg Sørensen
[Multiple Sclerosis Treatment Registry].
Ugeskrift for laeger 2012;174(42):2537.
2012: Poul Erik H Jensen; Nils Koch-Henriksen; Finn Sellebjerg; Per S Sørensen
Prediction of antibody persistency from antibody titres to natalizumab.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(10):1493-9.
2012: Marloes T Bazelier; Joan Bentzen; Frank de Vries; Hubert G M Leufkens; Tjeerd-Pieter van Staa; Peter Vestergaard; Nils Koch-Henriksen
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(5):622-7.
2011: Nils Koch-Henriksen; Per Soelberg Sorensen
Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?
Journal of the neurological sciences 2011;311(1-2):58-63.
2011: Mette Nørgaard; Egon Stenager; Jaimie L Gradus; Jacob Bonde Jacobsen; Nils Koch-Henriksen; Timothy L Lash; Rikke Beck Nielsen; Henrik Toft Sørensen
Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study.
American journal of epidemiology 2011;174(8):945-8.
2011: Per Soelberg Sørensen; Christian Vedeler; Poul Erik Hyldgaard Jensen; Anna Fogdell-Hahn; Aiden Haghikia; Jan Hillert; Nils Koch-Henriksen; Malin Lundkvist; Kjell-Morten Myhr; Finn Sellebjerg; Ralf Gold
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(9):1074-8.
2011: Lau Caspar Thygesen; Niels Keiding; Nils Koch-Henriksen
Evaluating a parametric model to correct multiple sclerosis incidence for reporting delay.
Statistics in medicine 2011;30(8):896-8.
2011: Per Soelberg Sørensen; Nils Koch-Henriksen; Poul Erik Hyldgaard Jensen
Neutralizing antibodies against interferon-β do not predispose antibodies against natalizumab.
Neurology 2011;76(8):759-60.
2010: C C H Pfleger; E M Flachs; Nils Koch-Henriksen
Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(11):1346-51.
2010: Stephan Bramow; Josa M Frischer; Hans Lassmann; Nils Koch-Henriksen; Claudia F Lucchinetti; Per S Sørensen; Henning Laursen
Demyelination versus remyelination in progressive multiple sclerosis.
Brain : a journal of neurology 2010;133(10):2983-98.
2010: Christian Enevold; Annette Oturai; Per Soelberg Sørensen; lars peter ryder; Nils Koch-Henriksen; Klaus Bendtzen
Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(8):942-9.
2010: C C H Pfleger; E M Flachs; Nils Koch-Henriksen
Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(7):878-82.
2010: Nils Koch-Henriksen; Per Soelberg Sørensen
The changing demographic pattern of multiple sclerosis epidemiology.
Lancet neurology 2010;9(5):520-32.
2010: Joan Bentzen; Esben Meulengracht Flachs; Egon Stenager; Henrik Brønnum-Hansen; Nils Koch-Henriksen
Prevalence of multiple sclerosis in Denmark 1950--2005.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(5):520-5.
2010: Claudia Christina Hilt Pfleger; Esben Meulengracht Flachs; Nils Koch-Henriksen
Social consequences of multiple sclerosis (1): early pension and temporary unemployment--a historical prospective cohort study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(1):121-6.
2009: Christian Enevold; Annette Bang Oturai; Per Soelberg Sørensen; lars peter ryder; Nils Koch-Henriksen; Klaus Bendtzen
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
Journal of neuroimmunology 2009;212(1-2):125-31.
2009: T R Nielsen; Klaus Rostgaard; Johan Askling; R Steffensen; A Oturai; Casper Jersild; Nils Koch-Henriksen; P S Sørensen; Henrik Hjalgrim
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):431-6.
2009: Nils Koch-Henriksen
No shortcuts to outcome in MS clinical trials?
Neurology 2009;72(8):686-7.
2008: N M Nielsen; Morten Frisch; Klaus Rostgaard; J Wohlfahrt; Henrik Hjalgrim; Nils Koch-Henriksen; M Melbye; Tine Westergaard
Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):823-9.
2008: P S Sorensen; Nils Koch-Henriksen; E M Flachs; Klaus Bendtzen
Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):837-42.
2007: Per Soelberg Sorensen; Nils Koch-Henriksen; Klaus Bendtzen
Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):616-21.
2007: Trine Rasmussen Nielsen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Sven Haahr; Per Soelberg Sørensen; Henrik Hjalgrim
Multiple sclerosis after infectious mononucleosis.
Archives of neurology 2007;64(1):72-5.
2006: Nete Munk Nielsen; Tine Westergaard; Morten Frisch; Klaus Rostgaard; Jan Wohlfahrt; Nils Koch-Henriksen; Mads Melbye; Henrik Hjalgrim
Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.
Archives of neurology 2006;63(7):1001-4.
2006: Peter Bager; Nete Munk Nielsen; Kristine Bihrmann; Morten Frisch; Jan Wohlfart; Nils Koch-Henriksen; Mads Melbye; Tine Westergaard
Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark.
American journal of epidemiology 2006;163(12):1112-7.
2006: Henrik Brønnum-Hansen; Thomas Hansen; Nils Koch-Henriksen; Egon Stenager
Fatal accidents among Danes with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):329-32.
2006: Per Soelberg Sorensen; Nils Koch-Henriksen; Mads Ravnborg; Jette Lautrup Frederiksen; Kai Jensen; Anne Heltberg; Hanne Schaldemose; Sven Deth; Ole Kristensen; Mogens Worm; Egon Stenager; Hans Jacob Hansen; Bjarne Sivertsen; Jesper Torring
Immunomodulatory treatment of multiple sclerosis in denmark: a prospective nationwide survey.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):253-64.
2006: Bodil Petersen; Klaus Bendtzen; Nils Koch-Henriksen; Mads Ravnborg; Christian Ross; Per Soelberg Sorensen
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):247-52.
2006: Nils Koch-Henriksen; Per Soelberg Sørensen; T Christensen; Jette Lautrup Frederiksen; Mads Ravnborg; Kai Jensen; A Heltberg; Ole Kristensen; Egon Stenager; Thor Petersen; T Hansen
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Neurology 2006;66(7):1056-60.
2006: Nete Munk Nielsen; Klaus Rostgaard; Søren Rasmussen; Nils Koch-Henriksen; Hans H Storm; Mads Melbye; Henrik Hjalgrim
Cancer risk among patients with multiple sclerosis: a population-based register study.
International journal of cancer. Journal international du cancer 2006;118(4):979-84.
2006: Christian Ross; Katja Maria Clemmesen; Per Soelberg Sørensen; Nils Koch-Henriksen; Klaus Bendtzen
Measuring and evaluating interferon beta-induced antibodies in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(1):39-46.
2005: Finn Sellebjerg; C Ross; Nils Koch-Henriksen; Per Soelberg Sørensen; Jette Lautrup Frederiksen; Klaus Bendtzen; Torben Lykke Sørensen
CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(6):641-5.
2005: Nete Munk Nielsen; Tine Westergaard; Klaus Rostgaard; Morten Frisch; Henrik Hjalgrim; Jan Wohlfahrt; Nils Koch-Henriksen; Mads Melbye
Familial risk of multiple sclerosis: a nationwide cohort study.
American journal of epidemiology 2005;162(8):774-8.
2005: Henrik Brønnum-Hansen; Egon Stenager; E Nylev Stenager; Nils Koch-Henriksen
Suicide among Danes with multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2005;76(10):1457-9.
2005: Per Soelberg Sorensen; Nils Koch-Henriksen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Neurology 2005;65(1):33-9.
2005: Egon Stenager; Ralf Møller; Henrik Brønnum-Hansen; Nils Koch-Henriksen
[Multiple sclerosis: its change in prevalence in Denmark, 1950-1996, and its total prevalence in Danish counties in 1996].
Ugeskrift for laeger 2005;167(14):1500-2.
2004: Olga Basso; Rita Campi; Morten Frydenberg; Nils Koch-Henriksen; Henrik Brønnum-Hansen; Jørn Olsen
Multiple sclerosis in women having children by multiple partners. A population-based study in Denmark.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):621-5.
2004: Peter Bager; Nete Munk Nielsen; Kristine Bihrmann; Morten Frisch; Henrik Hjalgrim; Jan Wohlfart; Nils Koch-Henriksen; Mads Melbye; Tine Westergaard
Childhood infections and risk of multiple sclerosis.
Brain : a journal of neurology 2004;127(Pt 11):2491-7.
2004: Steen Sørensen; Nils Koch-Henriksen; Christian Ross Pedersen; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].
Ugeskrift for laeger 2004;166(41):3606-9.
2004: Henrik Hjalgrim; Søren Rasmussen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Lars Munksgaard; Hans H Storm; Mads Melbye
Familial clustering of Hodgkin lymphoma and multiple sclerosis.
Journal of the National Cancer Institute 2004;96(10):780-4.
2004: Henrik Brønnum-Hansen; Nils Koch-Henriksen; Egon Stenager
Trends in survival and cause of death in Danish patients with multiple sclerosis.
Brain : a journal of neurology 2004;127(Pt 4):844-50.
2004: Jiong Li; Christoffer Johansen; Henrik Brønnum-Hansen; Egon Stenager; Nils Koch-Henriksen; Jørn Olsen
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
Neurology 2004;62(5):726-9.
2003: Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager; Nils Koch-Henriksen
Antibodies to IFN-beta: the Danish National IFN-beta Project.
Neurology 2003;61(9 Suppl 5):S27-8.
2003: Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Jette Lautrup Frederiksen; Kai Jensen; Ole Kristensen; Thor Petersen; Søren Rasmussen; Mads Ravnborg; Egon Stenager; Nils Koch-Henriksen
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.
Lancet 2003;362(9391):1184-91.
2003: Egon Stenager; Henrik Brønnum-Hansen; Nils Koch-Henriksen
Risk of multiple sclerosis in nurse anaesthetists.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(4):427-8.
2003: Kristina Bacher Svendsen; Troels S Jensen; Kim Overvad; Hans Jacob Hansen; Nils Koch-Henriksen; Flemming W Bach
Pain in patients with multiple sclerosis: a population-based study.
Archives of neurology 2003;60(8):1089-94.
2003: Egon Stenager; Henrik Brønnum-Hansen; Nils Koch-Henriksen
The risk of multiple sclerosis in nurses: a population-based epidemiological study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):299-301.
2001: K Schreiber; Per Soelberg Sørensen; Nils Koch-Henriksen; A Wagner; Morten Blinkenberg; Claus Svarer; H C Petersen
Correlations of brain MRI parameters to disability in multiple sclerosis.
Acta neurologica Scandinavica 2001;104(1):24-30.
2001: Nils Koch-Henriksen; S Rasmussen; Egon Stenager; M Madsen
The Danish Multiple Sclerosis Registry. History, data collection and validity.
Danish medical bulletin 2001;48(2):91-4.
2000: Christian Ross; Katja Maria Clemmesen; Morten Svenson; Per Soelberg Sørensen; Nils Koch-Henriksen; G L Skovgaard; Klaus Bendtzen
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group.
Annals of neurology 2000;48(5):706-12.
2000: Nils Koch-Henriksen; Per Soelberg Sørensen
The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(3):172-5.
1999: Annette Oturai; F Larsen; lars peter ryder; Hans O Madsen; Jan Hillert; Sten Fredrikson; Magnhild Sandberg-Wollheim; M Laaksonen; Nils Koch-Henriksen; Stephen Sawcer; L Fugger; Per Soelberg Sorensen; Arne Svejgaard
Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis.
Annals of neurology 1999;46(4):612-6.
1998: Nils Koch-Henriksen; Henrik Brønnum-Hansen; Egon Stenager
Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry.
Journal of neurology, neurosurgery, and psychiatry 1998;65(1):56-9.
1997: E N Stenager; Nils Koch-Henriksen; Egon Stenager
[Risk factors for suicide in patients with disseminated sclerosis].
Ugeskrift for laeger 1997;159(18):2690-3.